Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia
The Effect and Safety of Accelerated Continuous Theta-burst Stimulation on Metabolic Dysfunction in People With Schizophrenia
1 other identifier
interventional
40
1 country
1
Brief Summary
cTBS is a promising novel intervention, which has strong potential on moderating disease syndrome. However, the most effective pattern of the cTBS is still under debate. Therefore, the investigators designed this randomized controlled clinical trial to evaluate the efficacy and safety of accelerated cTBS, with 1800 stimulation per session, on intervention to metabolic side effects in individuals with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Jun 2022
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2022
CompletedFirst Posted
Study publicly available on registry
May 3, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2023
CompletedNovember 21, 2022
November 1, 2022
6 months
April 28, 2022
November 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change of body weight
the change of participants weight
from baseline to 6 weeks
Change of body mass index
the change of participants BMI
from baseline to 6 weeks
Secondary Outcomes (5)
Positive and Negative syndrome rating scale
from baseline to 6 weeks
Three Factor Eating Questionnaire
from baseline to 6 weeks
Barrat impulsiveness scale
from baseline to 6 weeks
Self-Control Scale
from baseline to 6 weeks
Food picture stimulation Event-related potentials
from baseline to 6 weeks
Study Arms (2)
Real stimulation
EXPERIMENTALParticipants in the real stimulation group will receive accelerated cTBS with 1800 stimulation per session for 10 consecutive days, 5 sessions per day with a gap at least one hour, 50 sessions in total. The stimulation will be conducted at left M1 area.
Sham stimulation
SHAM COMPARATORParticipants in the sham stimulation group will receive the stimulation with coil vertical to the surface with other settings same as the real stimulation group.
Interventions
cTBS was administered at 80% of each participant's M1 area in a burst-firing pattern (3 pulses at 50 Hz) with a repetition frequency of 5 Hz (200 ms intervals). During each session, participants received 1800 pulses (120 s).
Similar process with the accelerated theta burst stimulation with the coil 90 degrees tilted to the surface of the scalp, which could produce identical sound and vibration while avoiding real magnetic stimulation.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with schizophrenia in accordance with DSM-5
- BMI over 24
- Accepting antipsychotics stable treatment for more then 2 months
You may not qualify if:
- Diagnosed with other mental disease in accordance with DSM-5
- Comorbid with other severe physiological disease
- Used antipsychotic, antidepressants, mood stabilizer, or other psychoactive substances before
- Drug or alcohol abuse
- Pregnant or lactating Contraindication to rTMS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Xiangya Hospital Central South University
Changsha, Hunan, 410000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The participants, care provider, investigator, and outcome assessor will be blind to the intervention except the treatment provider.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 28, 2022
First Posted
May 3, 2022
Study Start
June 1, 2022
Primary Completion
December 1, 2022
Study Completion
May 1, 2023
Last Updated
November 21, 2022
Record last verified: 2022-11